##  [Compilation, Evaluation and Submission of Controlled Correspondence](/index%2ephp/case-studies/compilation-evaluation-and-submission-of-controlled-correspondence) 

- [Medicinal Products](/index%2ephp/case-studies-main-categories/medicinal-products)
- [Regulatory Affairs](/index%2ephp/case-studies-main-categories/regulatory-affairs)





[US FDA](/index%2ephp/case-studies-heath-authority/us-fda)

 

 ![Compilation, Evaluation and Submission of Controlled Correspondence]()

Submission of the Annual Report (AR) requires a comprehensive understanding of the Regulatory framework. One (1) of our leading Italian pharmaceutical development clients approached Freyr with a business imperative to compile, evaluate, and submit an AR to the US FDA.

The client received complete benefit and understanding through Freyr’s Regulatory Affairs and Operations team's support, which included internal reviews and necessary updated documentation support.

Download the proven case now.



Fill the form below to download the Case Study

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name